Larsson P

No ORCID on file · 4 papers in corpus
2023
Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocol.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01090-w

PurposeTo explore the efficacy and safety of individualized follitropin delta dosing, based on serum anti-Müllerian hormone (AMH) concentration and bodyweight, in a long gonadotropin-releasing hormone (GnRH) agonist protocol.MethodsClinical…

2022
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deac061

Study questionDoes addition of choriogonadotropin beta (recombinant CG beta) to follitropin delta increase the number of good-quality blastocysts following ovarian stimulation in a long GnRH agonist protocol?Summary answerAt the doses inves…

2022
Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing.
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1004596

BackgroundChoriogonadotropin (CG) beta (FE 999302), a novel recombinant human (h)CG produced by a human cell line, has a longer half-life and higher potency than CG alfa produced by a Chinese hamster ovary cell line. hCG augments steroid pr…

2022
Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study).
Frontiers in endocrinology ·doi:10.3389/fendo.2022.992677

ObjectiveTo observe the real-world utilization patterns, effectiveness and safety profile of follitropin delta in women ≥18 years naïve to ovarian stimulation undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI…